Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 16, 2021
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
[ Fri, Jul 16th 2021
] - WOPRAI
Andrew Berens Maintained (AZN) at Buy with Decreased Target to $63 on, Jul 16th, 2021
Andrew Berens of SVB Leerink, Maintained "AstraZeneca PLC" (AZN) at Buy with Decreased Target from $64 to $63 on, Jul 16th, 2021.
Andrew has made no other calls on AZN in the last 4 months.
There are 2 other peers that have a rating on AZN. Out of the 2 peers that are also analyzing AZN, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Monday, April 12th, 2021
This is the rating of the analyst that currently disagrees with Andrew
- Peter Welford of "Jefferies" Upgraded from Hold to Strong Buy on, Tuesday, March 16th, 2021
